Please login to the form below

Not currently logged in
Email:
Password:

teriflunomide

This page shows the latest teriflunomide news and features for those working in and with pharma, biotech and healthcare.

Sanofi licences Principia MS drug in $805m deal

Sanofi licences Principia MS drug in $805m deal

Sanofi ‘s established oral MS therapy is Aubagio (teriflunomide), which got off to a slow start after its launch in 2012 in the face of competition from rival drugs from Biogen

Latest news

More from news
Approximately 7 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics